BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...
Nuvilex has announced last week that it has acquired the exclusive worldwide rights to a cellulose-based live-cell encapsulation technology for the development of treatments for diabetes. In order to pull off the acquisition, Nuvilex had ...
Tags: Nuvilex, Diabetes Technology
NanoViricides has secured orphan drug designation from the European Medicines Agency (EMA) for its drug candidate DengueCide, for the treatment of dengue and dengue hemorrhagic fever. Dengue fever is a mosquito-borne disease that affects ...
Tags: Nanoviricides Drug
Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...
Tags: Helsinn group, Pharma Marketing
Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, has announced that the US Food and Drug Administration (FDA) has cleared the company's investigational new drug ...
Tags: Discovery Labs, Medicine
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
Lupin Pharmaceuticals (LPI), a US subsidiary of India-based Lupin, has launched its generic Rabeprazole Sodium delayed-release tablets, 20mg. Earlier, the company had received final approval from the US Food and Drug Administration (FDA) ...
Tags: Lupin Pharma, tablets
Emerson Process Management, a business of Emerson, has opened its new $25 million global headquarters for the design, testing and manufacture of regulator technologies, including pressure regulator and relief valve solutions to help oil and ...
Tags: Emerson, technology, global, headquarter
Israeli bio-medical engineering company ITGI Medical has signed a strategic cooperation agreement with Vascular Solutions, a medical device company, to commercialize ITGI's Aneugraft Dx coronary covered stent in the US market. Pursuant to ...
Tags: ITGI Medical, Aneugraft DX Stent
US-based AngioScore has presented six-month clinical and quantitative coronary angiography results from the first-in-human (FIH) clinical trial of its drug-coated AngioSculpt PTCA scoring balloon catheter at the Transcatheter Cardiovascular ...
Tags: AngioScore, Balloon Catheter
US-based Cochlear has announced that an advisory committee to the US Food and Drug Administration (FDA) voted favorably on the Cochlear Nucleus Hybrid L24 implant system. This is a first of its kind system designed for the treatment of ...
Bupa has announced its partnership deal with UK Sport is to continue until March 2014. This is an extension of the 2011 deal, whereby Bupa became the ‘Official Health Insurance Partner of UK Sport’. The partnership means Bupa ...
Tags: Health Insurance, Bupa
The Nissan Skyline will live on as a mildly tweaked version of the Infiniti Q50 Hybrid in Japan. Nissan confirmed the new version of the iconic nameplate, which dates back to 1955, would be almost identical to the Q50 sedan destined for ...
A new experimental carbon black pigment from Orion Engineered Carbons, XPB 255, features colorimetric properties ideal for high-jet automotive coatings as well as both solventborne and waterborne polyurethane (PU) coating systems. It is ...
Tags: Orion, carbon black pigment, coating, automotive, appliance
Ashland Water Technologies, a commercial unit of Ashland Inc., has hired Jeff Fulgham as vice president, marketing. He is based in Wilmington, Delaware and reports to John Panichella, Ashland senior vice president and president, Ashland ...